The Immunology of Ablative Radiation

Seminars in Radiation Oncology

Volumn 25, Issue 1, 2015, Pages 40-45

  Burnette, Byron ^a   Weichselbaum, Ralph R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ABLATIVE RADIATION; CANCER IMMUNOLOGY; CANCER RADIOTHERAPY; CELL KILLING; CELL MEDIATED CYTOTOXICITY; CLINICAL OBSERVATION; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; NONHUMAN; RADIATION DOSE; RADIATION RESPONSE; REVIEW; SENSITIZATION; STEREOTACTIC BODY RADIATION THERAPY; ANIMAL; IMMUNOLOGY; NEOPLASMS; PROCEDURES; RADIOSURGERY;

ANIMALS; HUMANS; NEOPLASMS; RADIOSURGERY;

EID: 84919493307     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2014.07.009     Document Type: Review

References (54)

1. Stone H.B., Peters L.J., Milas L. Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma. J Natl Cancer Inst 1979, 63:1229-1235.
2. Demaria S., Ng B., Devitt M.L. Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 2004, 58:862-870.
3. Lugade A.A., Moran J.P., Gerber S.A. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J Immunol 2005, 174:7516-7523.
4. + T cells: Changing strategies for cancer treatment. Blood 2009, 114:589-595.
5. Gough M.J., Crittenden M.R., Sarff M. Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. J Immunother 2010, 33:798-809.
6. Demaria S., Formenti S.C. Radiation as an immunological adjuvant: Current evidence on dose and fractionation. Front Oncol 2012, 2:153.
7. Formenti S.C., Demaria S. Systemic effects of local radiotherapy. Lancet Oncol 2009, 10:718-726.
8. Burnette B., Weichselbaum R.R. Radiation as an immune modulator. Semin Radiat Oncol 2013, 23:273-280.
9. Golden E.B., Pellicciotta I., Demaria S. The convergence of radiation and immunogenic cell death signaling pathways. Front Oncol 2012, 2:88.
10. Bashford EF, Russell B: Further evidence on the homogeneity of the resistance to the implantation of malignant new growths. Proceedings of the Royal Society of London Series B. Containing Papers of a Biological Character 298-306, 1910.
11. DiGiacomo A., North R.J. T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity. J Exp Med 1986, 164:1179-1192.
12. Turk M.J., Guevara-Patiño J.A., Rizzuto G.A. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 2004, 200:771-782.
13. Vaage J. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue. Cancer Res 1971, 31:1655-1662.
14. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 2005, 201:779-791.
15. Reits E.A., Hodge J.W., Herberts C.A. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006, 203:1259-1271.
16. Wan S., Pestka S., Jubin R.G. Chemotherapeutics and radiation stimulate MHC Class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS ONE 2012, 7(3):e32542.
17. Santin A.D., Hermonat P.L., Ravaggi A. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma. Cancer 1998, 83:2346-2352.
18. Sharma A., Bode B., Wenger R.H. γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE 2011, 6(11):e28217.
19. Gasser S., Orsulic S., Brown E.J. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436:1186-1190.
20. Chakraborty M., Abrams S.I., Coleman C.N. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res 2004, 64:4328-4337.
21. Burnette B., Fu Y.-X., Weichselbaum R.R. The confluence of radiotherapy and immunotherapy. Front Oncol 2012, 2:143.
22. Singh S., Ross S.R., Acena M. Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med 1992, 175:139-146.
23. Ochsenbein A.F., Klenerman P., Karrer U. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 1999, 96:2233-2238.
24. Spiotto M.T., Rowley D.A., Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat Med 2004, 10:294-298.
25. Spiotto M.T., Schreiber H. Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells. Cancer Immun 2005, 5:8.
26. Zhang B., Bowerman N.A., Salama J.K. Induced sensitization of tumor stroma leads to eradication of established cancer by T cells. J Exp Med 2007, 204:49-55.
27. Burnette B.C., Liang H., Lee Y. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res 2011, 71:2488-2496.
28. Widau R.C., Parekh A.D., Ranck M.C. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc Natl Acad Sci U S A 2014, 111:E484-E491.
29. Deng L., Liang H., Burnette B. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 2014, 124:687-695.
30. Wu C.Y., Yang L.H., Yang H.Y. Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res 2014, 20:644-657.
31. Binder D.C., Engels B., Arina A. Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer. Cancer Immunol Res 2013, 1:123-133.
32. Schaue D., Ratikan J.A., Iwamoto K.S. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2011, 83:1306-1310.
33. Kachikwu E.L., Iwamoto K.S., Liao Y.-P. Radiation enhances regulatory T cell representation. Int J Radiat Oncol Biol Phys 2011, 81:1128-1135.
34. Dunn P.L., North R.J. Adoptive immunotherapy of established tumors. Acquisition of radioresistance by tumor-specific T cells after passive transfer into tumor-bearing recipients. Int J Cancer 1994, 57:592-597.
35. North R.J. Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells. J Exp Med 1986, 164:1652-1666.
36. Garcia-Barros M. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
37. Gulbins E., Kolesnick R. Raft ceramide in molecular medicine. Oncogene 2003, 22:7070-7077.
38. Schietinger A., Arina A., Liu R.B. Longitudinal confocal microscopy imaging of solid tumor destruction following adoptive T cell transfer. Oncoimmunology 2013, 2:e26677.
39. Arina A., Schreiber K., Binder D.C. Adoptively transferred immune T cells eradicate established tumors despite cancer-induced immune suppression. J Immunol 2014, 192:1286-1293.
40. Mole R.H. Whole body irradiation; radiobiology or medicine?. Br J Radiol 1953, 26:234-241.
41. Kaminski J.M., Shinohara E., Summers J.B. The controversial abscopal effect. Cancer Treat Rev 2005, 31:159-172.
42. Nobler M.P. The abscopal effect in malignant lymphoma and its relationship to lymphocyte circulation. Radiology 1969, 93:410-412.
43. Ehlers G., Fridman M. Abscopal effect of radiation in papillary adenocarcinoma. Br J Radiol 1973, 46:220-222.
44. Kingsley D.P. An interesting case of possible abscopal effect in malignant melanoma. Br J Radiol 1975, 48:863-866.
45. Stamell E.F., Wolchok J.D., Gnjatic S. The abscopal effect associated with a systemic anti-melanoma immune response. Int J Radiat Oncol Biol Phys 2012, 85:293-295.
46. Takaya M., Niibe Y., Tsunoda S. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma-A case report. Anticancer Res 2007, 27:499-503.
47. Okuma K., Yamashita H., Niibe Y. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: A case report. J Med Case Rep 2011, 5:111.
48. Ohba K., Omagari K., Nakamura T. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998, 43:575-577.
49. Postow M.A., Callahan M.K., Barker C.A. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 2012, 366:925-931.
50. Golden E.B., Demaria S., Schiff P.B. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 2013, 1:365-372.
51. Seung S.K., Curti B.D., Crittenden M., et al. Phase 1 study of stereotactic body radiotherapy and interleukin-2-Tumor and immunological responses. Sci Transl Med 2012, 4:137-174.
52. Formenti S.C., Friedman K., Chao K. Abscopal response in irradiated patients: Results of a proof of principle trial. Int J Radiat Oncol Biol Phys 2008, 72:S6-S7.
53. Camphausen K., Moses M.A., Ménard C. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 2003, 63:1990-1993.
54. Dewan M.Z., Galloway A.E., Kawashima N. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009, 15:5379-5388.